Restylane® is a gel containing hyaluronic acid and lidocaine that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane® is a Class III medical device has risks and benefits. Restylane® treatment may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can begin up to two to four weeks after treatment in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved. Restylane® should not be used in an area where there is a non-resorbable implant or in irritated or infected skin, Restylane® should not be used in people taking blood thinning medicines or who have an allergy to hyaluronic acid, lidocaine or other local anaesthetics. Caution if you take medicines that prolong bleeding time. Treatment lasts 12-24 months. Restylane® has not been tested in pregnant or breast-feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland

Dysport® is a prescription medicine containing Clostridium botulinum Type A toxin complex for injection. It is used for the treatment of frown lines and excessive sweating. It should be administered only by trained medical professionals. Cautions: people with defective neuro-muscular transmission disorders, infection at site of injection, pregnancy and lactation. Possible side effects include headaches, pain, burning or redness at injection site, local muscle weakness including drooping eye lids, lack of feeling or nausea or compensatory sweating in other skin areas. Talk to your specialist about the benefits/risks of this procedure. A charge applies. Dysport® treatment lasts about three months and after this time further courses of treatment may be necessary.  Speak to your specialist about your own situation.

Relfydess® prescription medicine contains 150 units of relabotulinumtoxinA for the treatment of frown lines and crow’s feet around the eyes. Relfydess has risks and benefits. Ask your healthcare professional if Relfydess is right for you and to explain the possible side effects. Tell them if any side effects concern you. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. For details on precautions and side effects, see the Consumer Medicines Information at www.medsafe.govt.nz. Unfunded for aesthetic indications. Product and treatment costs apply. AUS: Galderma Australia Pty Ltd, Level 18, 1 Denison St, North Sydney, NSW 2060, Australia. ABN 12 003 976 930. NZ: Galderma Australia Pty Ltd, 58 Richard Pearse Drive, Airport Oaks, Mangere 2022. NZBN 9429051812249. Distributed in NZ by Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Mangere 2022, NZ.

Sunekos® is an implantable medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. It is suitable for creating a temporary increase in the volume of skin tissue. Sunekos 1200 is a medical device that is sterile, injectable, non-pyrogenic, biocompatible, re-absorbable, made with hyaluronic acid and amino acids. Sunekos Performa is a medical device recommended for the treatment of blemishes and depressions in the skin caused by wrinkles and scars. Sunekos Performa is a sterile resorbable injectable solution which acts as a filler, supporting the restoration of physiological elasticity and temporarily replacing volume by expanding the soft tissues. Sunekos should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full Instructions for use before prescribing for full safety information, available from

Profhilo®, containing low & high molecular weight hyaluronic acid, is a Class lll medical device for the treatment of the face and body for contours, redefinition and laxity remodelling where skin laxity is a problem. Profhilo® has risks and benefits. Do not use with treatments such as laser resurfacing or medium deep skin-peeling. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Individual results may vary. This medical device must be administered by a healthcare professional.

PROFHILO® STRUCTURA is a class 3 medical device and must be injected by a medical practitioner or a qualified nurse injector (operating under the supervision of a medical practitioner). PROFHILO® STRUCTURA [4.5% – 22.5 mg (H-HA) + 22.5 mg (L-HA)/1 ml Hyaluronic acid sodium salt and 4.5% – 45 mg (H-HA) + 45 mg (L-HA)/2 ml Hyaluronic acid sodium salt], injection gel in a single use sterile prefilled syringe. It is indicated for adults of both sexes for corrective / filling action of natural or induced skin depressions. PROFHILO® STRUCTURA has risks and benefits. Ask your healthcare professional if PROFHILO® STRUCTURA is right for you and to explain the possible side effects. WARNINGS & PRECAUTIONS: Do not use PROFHILO® STRUCTURA in case of known hypersensitivity or allergies to the components of the product. Do not use it in pregnant or breast-feeding women, in patients with autoimmune diseases. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. CONTRAINDICATIONS: PROFHILO® STRUCTURA must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. Tell your doctor if any side effects concern you. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Treatment costs and normal practitioner fees will apply. Please contact us for any further information or for the IFU (Instructions for use) of this product or for medical information or reporting any adverse effects.

Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles. Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age. Sculptra has unique injection requirements and should only be used by a trained healthcare practitioner. Contour deficiencies should not be overcorrected because they are expected to gradually improve after treatment. Sculptra should not be injected into the blood vessels as it may cause vascular occlusion, infarction or embolic phenomena. Use at the site of skin sores, cysts, pimples, rashes, hives or infection should be postponed until healing is complete. Sculptra should not be injected into the red area (vermillion) of the lip or in the peri-orbital area. The most common side effects after initial treatment include injection site swelling, tenderness, redness, pain, bruising, bleeding, itching and lumps. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported. Sculptra is available only through a licensed practitioner.